News of Note - March 3-4, 2023
BULL BEAR BRES|NAHAN
Saturday, March 4, 2023
As of --> 09:10 EET
Programming update, the next week or two will see a pause in this, I know, we only just restarted sending stuff out into the ether.. Personal/ family business to tend to.. See you on the other side..
In healthcare land you're seeing pharma start to push back, could get interesting out there; seems they're not in the mood to be pushed around any longer..
As Art Cashin says, stay nimble..
And let me add, don’t whipsaw yourself!!
😊
Br. -john
*PRESS RELEASES*
KROS
Keros Therapeutics [bio]
Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
LLY
Eli Lilly [cc: PFE & NOVN SW | NVS]
BMY
Bristol Myers Squibb
Third authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with diseases impacted by anemia
VERV
Verve Therapeutics [bio]
SAABB SS
Saab
Receives Carl-Gustaf Ammunition Order from Lithuania
HNSA SS
Hansa [bio]
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
EQNR NO | EQNR
Equinor
ERICA SS | ERICB SS | ERIC
Ericsson
U.S. Department of Justice Resolves 2019 Deferred Prosecution Agreement Breaches with Ericsson
ARDX
Ardelyx [bio]
Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
HII
Huntington Ingalls Industries
HII and Ocean Aero to Partner on Advanced Unmanned Maritime Capabilities
ILMN & MYGN
Illumina & Myriad Genetics
Expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry
AZN SS | AZN LN | AZN & MRK
AstraZeneca & Merck
Update on US regulatory review of Lynparza in combination with abiraterone for mCRPC
PHIA NA | PHG
Koninklijke (Royal) Philips
GEHC
GE HealthCare
The two companies will offer healthcare organizations a holistic program that goes beyond the traditional break-fix approach to medical device maintenance
Advantus Health Partners will leverage the expanded relationship to support quality care and sustainable cost reductions for its clients
MTNB
Matinas BioPharma [bio]
Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID
BMY & JNJ
Bristol Myers Squibb & Janssen (J&J)
VERV
Verve Therapeutics [bio]
Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
MOR GY | MOR
MorphoSys [bio]
Stops Work and Operations on Pre-Clinical Research Programs
*ARTICLES, ETC.*
Endpoints
UK and pharma (generic and branded) going to war..
UK government plans to hike revenue clawback rates beginning in April
Roche, Exelixis' Tecentriq/Cabometyx combo flunks second PhIII
Nature
Pablo Escobar’s ‘cocaine hippos’ spark conservation row
Researchers worry Colombian environment ministry will side with animal-rights activists rather than curb the invasive animals’ spread.
Bloomberg
What Now for a Fed That Has Fallen Behind the Curve Again?
The central bank downshifted rate increases too early and now faces a set of dilemmas and another knock to its credibility. - El-Erian
Who Owns Train Cars? Hint: Usually Not the Railroad
Private owners such as shippers and lessors account for about two-thirds of the cars operating on North American tracks, and maintenance obligations typically fall to them.
Blackstone Defaults on Nordic CMBS as Property Values Wobble
The notes are backed by a portfolio of offices and stores
Blackstone has been trying to sell the underlying properties
Toblerone Is Barred From Using the Iconic Swiss Mountain on Its Logo
Big Food Brands Struggling to Kick Junk Addiction, Survey Finds
Kraft Heinz, Nestle, Unilever, Kellogg rely on unhealthy food
Over 2,000 items sold in Australia, France, Mexico analyzed
Taylor Swift Boosts Universal Music’s Sales to $3.1 Billion
Universal Music Group’s sales rose 17% in the fourth quarter
Swift’s “Midnights” album sold over 6 million in eight weeks
Other
Ancient DNA upends European prehistory
Genes reveal striking diversity within similar ice age cultures
Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
Viatris warns it will stop selling essential drugs in UK without changes to drug pricing agreement
AstraZeneca, Merck's Lynparza to face FDA panel in prostate cancer bid as PARP scrutiny escalates
Obesity's global toll heads toward $4 trillion a year
How meningitis-causing bacteria invade the brain
Experiments in mice show the microbes hijack cells in the brain’s protective cover
Here’s how lemon juice may fend off kidney stones
Nanoparticles in the juice slowed the formation of the stones in rats
Evaluate
The sun sets on Exelixis’s pipeline in a product
After Cabometyx’s latest clinical setback Exelixis might have to turn to follow-on projects for future growth.
Spotlight – What is next in Nash
The next few months will see some important mid-stage Nash results, from Viking, 89Bio, Northsea and others.
GSK gets the vaccine edge on Pfizer
US experts favour GSK’s RSV vaccine over Pfizer’s, but both could be on the market soon.